Facts about injectable contraceptives: memorandum from a WHO meeting.
Bull World Health Organ
; 60(2): 199-210, 1982.
Article
en En
| MEDLINE
| ID: mdl-6213318
Palabras clave
Animals, Laboratory; Bleeding; Breast Feeding; Cancer; Carbohydrate Metabolic Effects; Clinical Research; Congenital Abnormalities; Contraception; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--side effects; Contraceptive Effectiveness; Contraceptive Methods; Diseases; Economic Factors; Family Planning; Fertility; Injectables; Medroxyprogesterone Acetate--side effects; Menstruation Disorders; Neoplasms; Norethindrone Enanthate--side effects; Norethindrone--side effects; Research And Development; Research Methodology; Signs And Symptoms; Technology; Use-effectiveness
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Medroxiprogesterona
/
Noretindrona
Tipo de estudio:
Clinical_trials
/
Prognostic_studies
Límite:
Animals
/
Female
/
Humans
/
Pregnancy
Idioma:
En
Revista:
Bull World Health Organ
Año:
1982
Tipo del documento:
Article
Pais de publicación:
Suiza